HCG Beta Total Quantitative Tumor Marker Test
Comprehensive Introduction to HCG Beta Total Testing
The HCG Beta Total Quantitative Tumor Marker Test represents a sophisticated diagnostic approach in modern oncology. This specialized blood test measures the beta subunit of human chorionic gonadotropin (HCG), a hormone that serves as a critical biomarker for several types of cancer. While HCG is naturally produced during pregnancy, elevated levels in non-pregnant individuals can indicate the presence of malignant tumors, making this test an essential tool for cancer detection, monitoring, and management.
What Does the HCG Beta Total Test Measure?
This advanced diagnostic test specifically quantifies the beta subunit of human chorionic gonadotropin using Chemiluminescent Microparticle Immunoassay technology. The test detects:
- Abnormal HCG beta levels indicating testicular germ cell tumors
- Elevated markers for ovarian cancer detection
- Gestational trophoblastic disease markers
- Recurrence monitoring for previously treated cancers
- Treatment response assessment in oncology patients
Who Should Consider This Important Screening?
This test is particularly recommended for individuals experiencing specific symptoms or with identified risk factors:
- Men with testicular lumps, swelling, or pain
- Women with unexplained pelvic pain or abnormal bleeding
- Individuals with family history of reproductive cancers
- Patients undergoing cancer treatment monitoring
- Those with previous cancer history requiring surveillance
- Individuals with persistent fatigue and unexplained weight loss
Significant Benefits of Early Detection
Choosing the HCG Beta Total Quantitative Tumor Marker Test provides multiple advantages:
- Early cancer detection when treatment is most effective
- Non-invasive testing with simple blood sample collection
- Accurate monitoring of treatment response and effectiveness
- Reliable recurrence detection for long-term surveillance
- Peace of mind through comprehensive health assessment
- Guided treatment decisions based on quantitative results
Understanding Your Test Results
Interpreting HCG Beta Total results requires professional medical guidance:
- Normal Range: Typically indicates no active tumor presence
- Elevated Levels: May suggest tumor activity requiring further investigation
- Trend Analysis: Serial testing helps monitor treatment progress
- Clinical Correlation: Results are interpreted alongside symptoms and imaging
- Follow-up Protocol: Abnormal results typically require additional testing
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $20 |
| Regular Price | $22 |
Nationwide Testing Accessibility
We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results with daily turnaround times.
Sample Requirements and Processing
The test requires 2 mL (1 mL minimum) serum collected from one SST tube. Samples are shipped refrigerated or frozen to maintain integrity. No special patient preparation is needed, making the testing process straightforward and convenient.
Take Control of Your Health Today
Don’t wait to address potential health concerns. The HCG Beta Total Quantitative Tumor Marker Test provides crucial information for early cancer detection and monitoring. With our affordable pricing and nationwide availability, proactive health screening has never been more accessible.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test and take the first step toward comprehensive health awareness and cancer prevention.
